missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SLC13A5 (aa 372-408) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (92%), Rat (92%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60679 (PA5-60679. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
S13A5 is a tricarboxylate plasma transporter with a preference for citrate.
Specifications
Specifications
| Accession Number | Q86YT5 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 284111 |
| Name | Human SLC13A5 (aa 372-408) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | EIEE25; Indy; mINDY; Na(+)/citrate cotransporter; Na+-coupled citrate transporter protein; NaC2/NaCT; NACT; novel solute carrier family 13 (sodium-dependent dicarboxylate transporter) (Slc13a2 or 3) member; SLC13A5; Sodium-coupled citrate transporter; sodium-dependent citrate transporter; sodium-dependent dicarboxylate transporter; solute carrier family 13 (sodium-dependent citrate transporter), member 5; solute carrier family 13 member 5 |
| Common Name | SLC13A5 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction